Hui-Ing Ma1,2, Marie Saint-Hilaire3, Cathi A Thomas3, Linda Tickle-Degnen4. 1. Department of Occupational Therapy, College of Medicine, National Cheng Kung University, 1 University Road, Tainan, 701, Taiwan. huingma@mail.ncku.edu.tw. 2. Institute of Allied Health Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan. huingma@mail.ncku.edu.tw. 3. Department of Neurology, Parkinson's Disease and Movement Disorders Center, Boston University Medical School, Boston Medical Center, Boston, MA, USA. 4. Department of Occupational Therapy, School of Arts and Sciences, Tufts University, Medford, MA, USA.
Abstract
PURPOSE: People with Parkinson's disease (PD) may experience stigma due to their visible features of movement and communication difficulties. This paper aimed to examine the role of experienced stigma in health-related quality of life (QOL), after controlling for personal and clinical characteristics. METHODS: This is a preliminary analysis of a subset of baseline data from the Social Self-Management of Parkinson's Disease Study (SocM-PD), an ongoing 3-year prospective cohort study. Seventy-three people with PD (M age = 65.72, 29 women) participated in this study. Hierarchical multiple regression analyses were used to determine the role of stigma in QOL, after controlling for gender, disease severity, depression, and motor difficulties of daily living. RESULTS: Significant correlations were found between QOL with gender (r = .26), disease severity (r = .38), depression (r = .65), motor difficulties of daily living (r = .71), and stigma (r = .83). After controlling for the significant covariates, stigma made a significant and unique contribution to the explanation of QOL by 13.7 % (p < 0.001). A final hierarchical multiple regression with stigma and the 4 covariates revealed an overall model that explained 77.8 % of the total variance of QOL (F [5, 63] = 48.79, p < 0.001). CONCLUSIONS: Experienced stigma appears to be a key determinant of QOL in people with PD. The results suggest the importance of further understanding stigma in PD to develop possible intervention strategies. Future work is also needed to verify the results with a larger and longitudinal dataset of the SocM-PD.
PURPOSE:People with Parkinson's disease (PD) may experience stigma due to their visible features of movement and communication difficulties. This paper aimed to examine the role of experienced stigma in health-related quality of life (QOL), after controlling for personal and clinical characteristics. METHODS: This is a preliminary analysis of a subset of baseline data from the Social Self-Management of Parkinson's Disease Study (SocM-PD), an ongoing 3-year prospective cohort study. Seventy-three people with PD (M age = 65.72, 29 women) participated in this study. Hierarchical multiple regression analyses were used to determine the role of stigma in QOL, after controlling for gender, disease severity, depression, and motor difficulties of daily living. RESULTS: Significant correlations were found between QOL with gender (r = .26), disease severity (r = .38), depression (r = .65), motor difficulties of daily living (r = .71), and stigma (r = .83). After controlling for the significant covariates, stigma made a significant and unique contribution to the explanation of QOL by 13.7 % (p < 0.001). A final hierarchical multiple regression with stigma and the 4 covariates revealed an overall model that explained 77.8 % of the total variance of QOL (F [5, 63] = 48.79, p < 0.001). CONCLUSIONS: Experienced stigma appears to be a key determinant of QOL in people with PD. The results suggest the importance of further understanding stigma in PD to develop possible intervention strategies. Future work is also needed to verify the results with a larger and longitudinal dataset of the SocM-PD.
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: Sze-Ee Soh; Jennifer L McGinley; Jennifer J Watts; Robert Iansek; Anna T Murphy; Hylton B Menz; Frances Huxham; Meg E Morris Journal: Qual Life Res Date: 2012-10-16 Impact factor: 4.147
Authors: Deepa Rao; Seung W Choi; David Victorson; Rita Bode; Amy Peterman; Allen Heinemann; David Cella Journal: Qual Life Res Date: 2009-04-25 Impact factor: 4.147
Authors: Linda Tickle-Degnen; Marie Saint-Hilaire; Cathi A Thomas; Barbara Habermann; Linda S Sprague Martinez; Norma Terrin; Farzad Noubary; Elena N Naumova Journal: BMC Neurol Date: 2014-05-02 Impact factor: 2.474
Authors: Allegra R Gordon; Nancy Krieger; Cassandra A Okechukwu; Sebastien Haneuse; Mihail Samnaliev; Brittany M Charlton; S Bryn Austin Journal: Qual Life Res Date: 2017-03-17 Impact factor: 4.147
Authors: Samia S Islam; Sandy Neargarder; Shraddha B Kinger; Joshua T Fox-Fuller; Robert D Salazar; Alice Cronin-Golomb Journal: Gen Psychiatr Date: 2022-06-22
Authors: Robert D Salazar; Emma Weizenbaum; Terry D Ellis; Gammon M Earhart; Matthew P Ford; Leland E Dibble; Alice Cronin-Golomb Journal: Parkinsonism Relat Disord Date: 2018-09-25 Impact factor: 4.891
Authors: Linda Tickle-Degnen; Michael T Stevenson; Sarah D Gunnery; Marie Saint-Hilaire; Cathi A Thomas; Linda Sprague Martinez; Barbara Habermann; Elena N Naumova Journal: Disabil Rehabil Date: 2020-04-01 Impact factor: 3.033
Authors: Nicholas R Boileau; Jane S Paulsen; Rebecca E Ready; Elizabeth A Hahn; Jin-Shei Lai; Noelle E Carlozzi Journal: Rehabil Psychol Date: 2020-01-20